GeneMe
Manufacturing · Poland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Kampinoska 25, Gdansk, Pomeranian Voivod...Phone Number
+48 517169126Website
www.geneme.euRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GeneMe
GeneMe is a biotech company specializing in genetic laboratory diagnostics, offering qPCR diagnostic kits for professionals. Their focus is on enhancing the accuracy and efficiency of genetic analysis, with the capability to develop new genetic tests in just four weeks using patented technology. The company targets professionals in the fields of single nucleotide polymorphisms, sexually transmitted infections, and infectious diseases. GeneMe is committed to advancing genetic testing solutions for healthcare providers.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GeneMe your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if GeneMe is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at GeneMe
Earning: See what the market has to say on GeneMe recently announced quarterly report
Product Launch: Get notified when GeneMe launches new products
GeneMe, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if GeneMe had a recent Job posting/layoffs
Check if GeneMe has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once GeneMe has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined GeneMe as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
GeneMe is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GeneMe is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GeneMe.
GeneMe financials insights
Gather financial insights about GeneMe, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$6.4M
GeneMe Tech Stack
A closer look at the technologies used by GeneMe
GeneMe News & Media
Poland’s GeneMe secures €5.2M seed funding for its rapid COVID-19 test
GeneMe, Poland-based biotechnology company with a COVID-19 test, has secured a €5.2M round of seed funding led by Robin Tombs, co-Founder of Yoti and previously of Gamesys, and other angel investors. The startup has developed and patented a universal protein (polymerase) for RT-LAMP testing, which allows the production of highly accurate, rapid, molecular genetic COVID […]Rishi Sunak Visits UK Manufacturer of COVID-19 Analysis Equipment
MIDDLESBROUGH, England--(BUSINESS WIRE)--IT-IS International welcomed Rishi Sunak to their UK R&D and Production facility where he got hands-on with their MyGoTM qPCR instrumentation that is currently being deployed in six continents to help contain the spread of COVID-19. Rishi Sunak, MP for Richmond said “It is great to see British engineering at the forefront of the fight against COVID-19.” Rishi was very keen to learn more about the technology behind the MyGoTM qPCR instrumentation and
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GeneMe
Sign Up For FreeTo access detailed company insights
GeneMe is a biotech company specializing in genetic laboratory diagnostics, offering qPCR diagnostic kits for professionals. Their focus is on enhancing the accuracy and efficiency of genetic analysis, with the capability to develop new genetic tests in just four weeks using patented technology. The company targets professionals in the fields of si... Read More
